ANGELA GILL: Open Payments
NPI 1952894578 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,435 in 12 payments from 6 companies in 2025. Trend: 2023 $2,213 · 2024 $2,353 · 2025 $1,435
Food & beverage: $1,435
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $375 |
| Alexion Pharmaceuticals, Inc. | 3 | $375 |
| Gilead Sciences, Inc. | 3 | $331 |
| Verona Pharma, Inc. | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. | 1 | $118 |
| Amgen Inc. | 1 | $112 |
Products named: FASENRA, ULTOMIRIS, Yeztugo, Ohtuvayre, CAMZYOS, TAVNEOS.
Industry payments across WI — which companies pay providers there.
